Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 138 entries
View as:

To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00913237 Org: User:
Start: 07/31/87 End: 08/31/87 Due: 08/31/88

Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)

Phase: N/A Priority: Normal
NCT ID: NCT00959439 Org: User:
Start: 03/31/02 End: 05/31/02 Due: 05/31/03

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02744755 Org: User:
Start: 03/31/16 End: 09/26/17 Due: 09/26/18

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00882570 Org: User:
Start: 04/30/05 End: 05/31/05 Due: 05/31/06

A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

Phase: N/A Priority: Normal
NCT ID: NCT02920242 Org: User:
Start: 12/15/16 End: 05/23/17 Due: 05/23/18

Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

Phase: N/A Priority: Normal
NCT ID: NCT01766934 Org: User:
Start: 05/31/11 End: 08/29/24 Due: 08/29/25

Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold

Phase: N/A Priority: Normal
NCT ID: NCT05070650 Org: User:
Start: 09/20/24 End: 04/30/25 Due: 04/30/26

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00883064 Org: User:
Start: 03/31/00 End: 04/30/00 Due: 04/30/01

Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT05633771 Org: User:
Start: 02/16/23 End: 12/31/26 Due: 12/31/27

Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00866216 Org: User:
Start: 08/31/03 End: 09/30/03 Due: 09/30/04

To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00913952 Org: User:
Start: 04/30/94 End: 06/30/94 Due: 06/30/95

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00946621 Org: User:
Start: 10/31/04 End: 11/30/04 Due: 11/30/05

Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT05311475 Org: User:
Start: 04/04/22 End: 06/20/23 Due: 06/20/24

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00857142 Org: User:
Start: 11/30/07 End: 12/31/07 Due: 12/31/08

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00946387 Org: User:
Start: 09/30/04 End: 09/30/04 Due: 09/30/05

Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat

Phase: N/A Priority: Normal
NCT ID: NCT03095508 Org: User:
Start: 02/22/17 End: 05/08/17 Due: 05/08/18

To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00882882 Org: User:
Start: 06/30/01 End: 06/30/01 Due: 06/30/02

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00946751 Org: User:
Start: 03/31/04 End: 03/31/04 Due: 03/31/05

Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.

Phase: N/A Priority: Normal
NCT ID: NCT00632125 Org: User:
Start: 07/31/08 End: 09/30/10 Due: 09/30/11

To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00946491 Org: User:
Start: 04/30/87 End: 05/31/87 Due: 05/31/88

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00711958 Org: User:
Start: 11/30/04 End: 12/31/05 Due: 12/31/06

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00914160 Org: User:
Start: 08/31/93 End: 09/30/93 Due: 09/30/94

Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis

Phase: N/A Priority: Normal
NCT ID: NCT04123405 Org: User:
Start: 10/22/20 End: 04/20/21 Due: 04/20/22

Clinical Trial With Mesalamine 1g Suppositories

Phase: N/A Priority: Normal
NCT ID: NCT01172444 Org: User:
Start: 06/30/10 End: 12/31/12 Due: 12/31/13

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg

Phase: N/A Priority: Normal
NCT ID: NCT00913341 Org: User:
Start: 11/30/91 End: 11/30/91 Due: 11/30/92